Obinutuzumab for the treatment of chronic lymphocytic leukemia and other B-cell lymphoproliferative disorders. [electronic resource]
Producer: 20180206Description: 1463-1470 p. digitalISSN:- 1744-7682
- Antibodies, Monoclonal -- therapeutic use
- Antibodies, Monoclonal, Humanized -- adverse effects
- Antigens, CD20 -- immunology
- Antineoplastic Agents, Alkylating -- therapeutic use
- Antineoplastic Agents, Immunological -- adverse effects
- Clinical Trials as Topic
- Drug Therapy, Combination
- Half-Life
- Humans
- Leukemia, B-Cell -- drug therapy
- Leukemia, Lymphocytic, Chronic, B-Cell -- drug therapy
- Neutropenia -- etiology
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.